Intercept Pharmaceuticals to Present Phase 2a Portal Hypertension Data at AASLD’s Liver Meeting

[at noodls] – NEW YORK, Nov. 8, 2012 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel … more

View todays social media effects on ICPT

View the latest stocks trending across Twitter. Click to view dashboard